183 related articles for article (PubMed ID: 19569727)
1. Differential LC-MS-based proteomics of surgical human cholangiocarcinoma tissues.
Kawase H; Fujii K; Miyamoto M; Kubota KC; Hirano S; Kondo S; Inagaki F
J Proteome Res; 2009 Aug; 8(8):4092-103. PubMed ID: 19569727
[TBL] [Abstract][Full Text] [Related]
2. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.
Lukic N; Visentin R; Delhaye M; Frossard JL; Lescuyer P; Dumonceau JM; Farina A
Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482
[TBL] [Abstract][Full Text] [Related]
3. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
4. Shotgun proteomics of human bile in hilar cholangiocarcinoma.
Farid SG; Craven RA; Peng J; Bonney GK; Perkins DN; Selby PJ; Rajendra Prasad K; Banks RE
Proteomics; 2011 May; 11(10):2134-8. PubMed ID: 21500345
[TBL] [Abstract][Full Text] [Related]
5. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
[TBL] [Abstract][Full Text] [Related]
6. Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.
Kristiansen TZ; Harsha HC; Grønborg M; Maitra A; Pandey A
J Proteome Res; 2008 Nov; 7(11):4670-7. PubMed ID: 18839982
[TBL] [Abstract][Full Text] [Related]
7. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma.
Chua-On D; Proungvitaya T; Techasen A; Limpaiboon T; Roytrakul S; Wongkham S; Wongkham C; Somintara O; Sungkhamanon S; Proungvitaya S
Tumour Biol; 2016 Oct; 37(10):13659-13667. PubMed ID: 27473083
[TBL] [Abstract][Full Text] [Related]
8. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
Farina A; Dumonceau JM; Antinori P; Annessi-Ramseyer I; Frossard JL; Hochstrasser DF; Delhaye M; Lescuyer P
Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
[TBL] [Abstract][Full Text] [Related]
9. Secretomic profiling of cells from hollow fiber bioreactor reveals PSMA3 as a potential cholangiocarcinoma biomarker.
Verathamjamras C; Weeraphan C; Chokchaichamnankit D; Watcharatanyatip K; Subhasitanont P; Diskul-Na-Ayudthaya P; Mingkwan K; Luevisadpaibul V; Chutipongtanate S; Champattanachai V; Svasti J; Srisomsap C
Int J Oncol; 2017 Jul; 51(1):269-280. PubMed ID: 28560424
[TBL] [Abstract][Full Text] [Related]
10. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes.
Srisomsap C; Sawangareetrakul P; Subhasitanont P; Chokchaichamnankit D; Chiablaem K; Bhudhisawasdi V; Wongkham S; Svasti J
J Biomed Biotechnol; 2010; 2010():437143. PubMed ID: 20069059
[TBL] [Abstract][Full Text] [Related]
11. A comparative proteomic analysis of HepG2 cells incubated by S(-) and R(+) enantiomers of anti-coagulating drug warfarin.
Bai J; Sadrolodabaee L; Ching CB; Chowbay B; Ning Chen W
Proteomics; 2010 Apr; 10(7):1463-73. PubMed ID: 20140906
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinoma.
Padden J; Megger DA; Bracht T; Reis H; Ahrens M; Kohl M; Eisenacher M; Schlaak JF; Canbay AE; Weber F; Hoffmann AC; Kuhlmann K; Meyer HE; Baba HA; Sitek B
Mol Cell Proteomics; 2014 Oct; 13(10):2661-72. PubMed ID: 25034945
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of aquaporin-1 in intrahepatic cholangiocarcinoma is related to tumor progression and mucin expression.
Aishima S; Kuroda Y; Nishihara Y; Taguchi K; Iguchi T; Taketomi A; Maehara Y; Tsuneyoshi M
Hum Pathol; 2007 Dec; 38(12):1819-25. PubMed ID: 17854859
[TBL] [Abstract][Full Text] [Related]
14. p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
Tan FL; Ooi A; Huang D; Wong JC; Qian CN; Chao C; Ooi L; Tan YM; Chung A; Cheow PC; Zhang Z; Petillo D; Yang XJ; Teh BT
Int J Cancer; 2010 May; 126(10):2353-61. PubMed ID: 19816939
[TBL] [Abstract][Full Text] [Related]
15. Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.
Takadate T; Onogawa T; Fukuda T; Motoi F; Suzuki T; Fujii K; Kihara M; Mikami S; Bando Y; Maeda S; Ishida K; Minowa T; Hanagata N; Ohtsuka H; Katayose Y; Egawa S; Nishimura T; Unno M
Int J Cancer; 2013 Mar; 132(6):1368-82. PubMed ID: 22915188
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors).
Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW
Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of fascin, E-cadherin and vimentin: Proteins associated with survival of cholangiocarcinoma patients.
Mao X; Chen D; Wu J; Li J; Zhou H; Wu Y; Duan X
Am J Med Sci; 2013 Oct; 346(4):261-8. PubMed ID: 23221510
[TBL] [Abstract][Full Text] [Related]
18. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
[TBL] [Abstract][Full Text] [Related]
20. Loss of MTSS1 expression is an independent prognostic factor for Hilar cholangiocarcinoma.
Wang F; Liu Y; Zhang H
Pathol Oncol Res; 2013 Oct; 19(4):815-20. PubMed ID: 23852458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
